Carregant...
Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials
PURPOSE: To assess ultra-high (UH; PSA ≥ 50 ng/ml) patient outcomes compared to other high-risk patients and to identify outcome predictors. METHODS AND MATERIALS: PCP from two Phase III RTOG clinical trials (9202 and 9413) were divided into two groups; high-risk patients with and without UH baselin...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2952349/ https://ncbi.nlm.nih.gov/pubmed/20615632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.02.034 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|